National Comprehensive Cancer Network



About NCCN

Latin America Welcomes Back NCCN

By Kelly C. Simpson, Manager, Global Initiatives, Editor, eBulletin: International Edition

On July 9, 2011, the National Comprehensive Cancer Network® (NCCN®) leadership and faculty were again hosted by GLICO, Grupo Latino Americano de Investigação Clinica em Oncologia, as part of their annual congress. Participants gathered in the Sofitel Rio de Janeiro Copacabana Hotel to learn from esteemed NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) experts Joan S. McClure, MS, NCCN senior vice president, clinical information & publications, Dr. Al Benson, MD, FACP, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Dr. Gregory Otterson, MD, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, Dr. William Gradishar, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and Dr. Mohammad Jahanzeb, MD, FACP.

Ms. McClure provided an overview of NCCN products and services, focusing on the NCCN outcomes database and illustrating examples of data reporting. Dr. Benson, Dr. Otterson, and Dr. Gradishar educated the group on the latest recommendations of the NCCN Guidelines™ on Colon, Non-Small Cell Lung, and Breast Cancers. They described the decisions made by their tumor-specific panels and the data that ultimately drove the treatment decisions indicated in the algorithms.

Beyond those specific NCCN Guidelines presentations, the group additionally heard from Dr. Paulo M. Hoff, MD, Professor of Medicine and Chairman of Medical Oncology at the Instituto do Cancer do Estado de Sao Paulo, University of Sao Paulo. Dr. Hoff discussed some of the barriers to drug access in the region.

Finally, as the NCCN Global Medical Advisor, Dr. Mohammad Jahanzeb spoke about practical application of guidelines and their implementation in community practices.

At the close of the program, Dr. Carlos Barrios of GLICO told the audience, “I truly believe that the implementation of adapted NCCN Guidelines will have a significant impact on the way cancer is treated in Latin America.” This sentiment was echoed by the many participants who approached the NCCN faculty and staff to express their appreciation.